MART-1/Melan-A monoclonal (C-term) (Ascites), anti-human

Background:
MLANA is involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein SILV/PMEL17, which is critical to the formation of stage II melanosomes.

Other Names:
Melanoma antigen recognized by T-cells 1, MART-1, Antigen LB39-AA, Antigen SK29-AA, Protein Melan-A, MLANA, MART1

Target/Specificity:
This MART-1/Melan-A antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 60-92 amino acids from the C-terminal region of human MART-1/Melan-A.

Antigen Region:
60-92

Antigen Type: Synthetic Peptide

Gene Name: MLANA
Gene ID: 2315
Primary Accession: Q16655
NCBI Accession: NP_005502.1
Other Accession: NP_005502
Format: Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.